[{"Assets_0_Q1_USD":"477114000.0","CIK":"1706431","CommonStockSharesConverted_0_Q1_shares":"108350368.0","CommonStockSharesOutstanding_0_Q1_shares":"108350368.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.71","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-48409000.0","NetIncomeLoss_1_Q1_USD":"-77240000.0","OfficialName":"Vir Biotechnology Inc. Common Stock","ProfitLoss_1_Q1_USD":"-77240000.0","RevenuesConverted_1_Q1_USD":"5718000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"380333000.0","Ticker":"VIR","filed":"20200512","footnote":null,"form":"10-Q","fp":"Q1","fy":"2020.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20200331","qtrs":"0","uom":"USD"}]